LINC02427
gene geneOn this page
Summary
LINC02427 (long intergenic non-protein coding RNA 2427, HGNC:53358) is a long non-coding RNA gene on chromosome 4q35.1.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:53358 |
| Approved symbol | LINC02427 |
| Name | long intergenic non-protein coding RNA 2427 |
| Location | 4q35.1 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000271538 |
| Ensembl biotype | lncRNA |
| Entrez | 105377585 |
| RNAcentral | URS0000BC43EE — lncRNA, 1098 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 9 lncRNA
ENST00000604660, ENST00000605270, ENST00000696856, ENST00000772711, ENST00000772712, ENST00000772713, ENST00000772714, ENST00000772715, ENST00000772716
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000604660 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003466785 | 184509237 | 184509325 |
| ENSE00003593651 | 184509496 | 184509688 |
| ENSE00003650716 | 184506918 | 184507376 |
Expression profiles
Bgee: expression breadth ubiquitous, 124 present calls, max score 80.71.
FANTOM5 (CAGE): breadth broad, TPM avg 1.7225 / max 44.5915, expressed in 660 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 55149 | 1.5674 | 647 |
| 55148 | 0.1550 | 72 |
Top tissues by expression
127 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| quadriceps femoris | UBERON:0001377 | 80.71 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 71.95 | gold quality |
| bone marrow cell | CL:0002092 | 71.90 | gold quality |
| bone marrow | UBERON:0002371 | 71.81 | gold quality |
| cerebellar vermis | UBERON:0004720 | 67.75 | gold quality |
| thymus | UBERON:0002370 | 67.30 | silver quality |
| calcaneal tendon | UBERON:0003701 | 59.08 | gold quality |
| gall bladder | UBERON:0002110 | 59.00 | gold quality |
| prefrontal cortex | UBERON:0000451 | 57.67 | gold quality |
| ventricular zone | UBERON:0003053 | 57.59 | silver quality |
| skeletal muscle tissue | UBERON:0001134 | 56.98 | gold quality |
| muscle tissue | UBERON:0002385 | 56.93 | gold quality |
| lymph node | UBERON:0000029 | 56.58 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 56.42 | gold quality |
| temporal lobe | UBERON:0001871 | 56.31 | gold quality |
| amygdala | UBERON:0001876 | 56.00 | gold quality |
| corpus callosum | UBERON:0002336 | 55.90 | gold quality |
| tonsil | UBERON:0002372 | 55.59 | gold quality |
| nucleus accumbens | UBERON:0001882 | 55.46 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 55.42 | gold quality |
| frontal cortex | UBERON:0001870 | 55.20 | gold quality |
| spinal cord | UBERON:0002240 | 55.12 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 55.10 | gold quality |
| cortical plate | UBERON:0005343 | 54.99 | silver quality |
| substantia nigra | UBERON:0002038 | 54.65 | gold quality |
| hypothalamus | UBERON:0001898 | 54.47 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 54.35 | gold quality |
| cerebral cortex | UBERON:0000956 | 54.23 | gold quality |
| liver | UBERON:0002107 | 53.90 | silver quality |
| leukocyte | CL:0000738 | 53.76 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.73 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.